Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2007-6-1
pubmed:abstractText
Dysplasia and malignant transformation of colonocytes in ulcerative colitis are associated with overexpression of c-Myc and genes regulating cell survival. 5-Aminosalicylates such as mesalazine may reduce the development of colorectal cancer in ulcerative colitis, but the mechanisms of its chemopreventive action are not clear.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0269-2813
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1443-9
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Mesalazine downregulates c-Myc in human colon cancer cells. A key to its chemopreventive action?
pubmed:affiliation
Department of Medicine, Division of Gastroenterology, VA Long Beach Healthcare System, Long Beach, CA, USA. eric.chu2@med.va.gov
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't